These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 31637733)

  • 21. Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.
    Green CL; Kligfield P; George S; Gussak I; Vajdic B; Sager P; Krucoff MW
    Am Heart J; 2012 Mar; 163(3):365-71. PubMed ID: 22424006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, Four-Period Crossover Study To Evaluate the Effect of Gepotidacin on Cardiac Conduction as Assessed by 12-Lead Electrocardiogram in Healthy Volunteers.
    Hossain M; Zhou M; Tiffany C; Dumont E; Darpo B
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin.
    Couderc JP; McNitt S; Hyrien O; Vaglio M; Xia X; Polonsky S; Moss AJ; Zareba W
    Drug Saf; 2008; 31(3):249-60. PubMed ID: 18302449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects.
    Démolis JL; Kubitza D; Tennezé L; Funck-Brentano C
    Clin Pharmacol Ther; 2000 Dec; 68(6):658-66. PubMed ID: 11180026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?
    Makaryus AN; Byrns K; Makaryus MN; Natarajan U; Singer C; Goldner B
    South Med J; 2006 Jan; 99(1):52-6. PubMed ID: 16466123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
    Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.
    Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M
    Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
    Stier B; Fossler M; Liu F; Caltabiano S
    Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2.
    Eichenbaum G; Pugsley MK; Gallacher DJ; Towart R; McIntyre G; Shukla U; Davenport JM; Lu HR; Rohrbacher J; Hillsamer V
    Br J Pharmacol; 2012 Jul; 166(5):1694-707. PubMed ID: 22289150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of three fluoroquinolones on QT analysis after standard treatment courses.
    Tsikouris JP; Peeters MJ; Cox CD; Meyerrose GE; Seifert CF
    Ann Noninvasive Electrocardiol; 2006 Jan; 11(1):52-6. PubMed ID: 16472283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. R on T Phenomenon and Long QTc Syndrome due to Moxifloxacin in a Healthy Female.
    Anyfantakis D; Makrakis G
    P R Health Sci J; 2019 Sep; 38(3):196-197. PubMed ID: 31536636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization.
    Odening KE; Hyder O; Chaves L; Schofield L; Brunner M; Kirk M; Zehender M; Peng X; Koren G
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2264-72. PubMed ID: 18835916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Randomized Study of the Single-Dose Safety, Pharmacokinetics, and Food Effect of Chinfloxacin and Its Effect on Thorough QT/QTc Interval in Healthy Chinese Volunteers.
    Zhao C; Lv Y; Wei M; Li X; Hou F; Wang J; Ma X; Kang Z; Mao W; Liu Y; Xia Y; Tian J
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak-Tend analysis in the halothane-anesthetized beagle dogs.
    Cao X; Nakamura Y; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    J Toxicol Sci; 2016; 41(3):439-47. PubMed ID: 27193735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk.
    Johannesen L; Vicente J; Hosseini M; Strauss DG
    PLoS One; 2016; 11(12):e0166925. PubMed ID: 28036330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Celecoxib on the QTc Interval: A Thorough QT/QTc Study.
    Kim S; Lee H; Ko JW; Kim JR
    Clin Ther; 2019 Nov; 41(11):2204-2218. PubMed ID: 31564512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
    Kelleher D; Tombs L; Preece A; Brealey N; Mehta R
    Pulm Pharmacol Ther; 2014 Oct; 29(1):49-57. PubMed ID: 25020273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve.
    Vormberge T; Hoffmann M; Himmel H
    J Pharmacol Toxicol Methods; 2006; 54(2):130-40. PubMed ID: 16757186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy Subjects.
    Zhou D; So K; Dymond AW; Vik T; Al-Huniti N; Mariani G; Zorenyi G; Huang Y; Holmes V; Severin P; Rasmussen S; Martin P
    Clin Ther; 2016 Dec; 38(12):2555-2566. PubMed ID: 27837934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.